Display HSQ109635For more detailed information on a particular section refer to the help specific to that section. Times presented in this website are for Queensland (without daylight saving). Detailed Help (Clicking detailed help will open a new browser window) |
| ||||||||||||||||||||
Section 1 |
Tender Overview |
---|
Standing Offer Arrangement for the Provision of General Pharmaceuticals – Anti-infectives, Antineoplastics and Immunomodifiers (Request for Offer No. HSQ109635). This tender is for the supply of Anti-infectives, Antineoplastics and Immunomodifiers to Central Pharmacy (Queensland Health's distribution warehouse for pharmaceuticals located at Richlands). Due to the current changes occurring in the market for the above products, Queensland Health has decided to approach the market to seek offers to confirm best value for money is being achieved. The following lines are being called in the Request for Offer document -
All offerors will be assessed against the same evaluation criteria. This tender process may result in changes to the List of Approved Medicines (LAM) and/or the addition of other products to the General Pharmaceutical SOA. All tender clarification questions must be directed to Queensland Health via the 'Ask a Question' function in QTenders. Clarification Close Date: no later than 2:00pm (AEST) on Monday, 20 September 2021. DoH will respond to all clarifications by QTenders. Current Pharmaceutical Header Arrangement (PHA) holder. It is acknowledged that you have previously provided the information being requested in Schedule D - Response Forms in the RFO pack. On this basis, this information does not need to be resubmitted if the information is unchanged. However, if you need to advise of changes, these must be advised in the relevant Response Forms when responding. In August 2019, the Ethical Supplier Threshold was introduced to the Queensland Government Procurement model. It is necessary that you complete Response Form 11 in the RFO to satisfy this requirement. More information can be found here https://www.epw.qld.gov.au/about/strategy/buy-qld/about/ethical-suppliers
Addendum 31/08/2021 - Closing date updated on RFO Pricing Sheet [RFO Pricing Sheet Anti-infectives Antineoplastics Immunomodifiers V1.02] Notes - Clarification to FAQ21/09/2021: Samples –SP is unable to confirm at this stage which products will need to be sampled because the tender has not closed, however, -
Information on Samples – Page 13; HSQ109635A Queensland Health Strategic Procurement Officer will contact all offerors shortly after the tender closes to advise which products need to be provided as samples. The sample delivery period is within 5 business days upon the Contact Officer requesting samples.
10.Goods must correspond with sample
11.sample REQUIREMENTS
Each product sample supplied must be clearly labelled as per below:
12.sample delivery
Current Pharmaceutical Header Arrangement (PHA) holdersIt is acknowledged that you have previously provided the information being requested in Schedule D - Response Forms in the RFO pack. On this basis, this information does not need to be resubmitted if the information is unchanged. However, if you need to advise of changes, these must be advised in the relevant Response Forms when responding. In August 2019, the Ethical Supplier Threshold was introduced to the Queensland Government Procurement model. It is necessary that you complete Response Form 11 in the RFO to satisfy this requirement. All offerors will be assessed against the same evaluation criteria. This tender process may result in changes to the List of Approved Medicines (LAM) and/or the addition of other products to the Standing Offer Arrangement (SOA). Provision of Supporting Documentation; RFO Pricing Sheet Anti-infectives Antineoplastics Immunomodifiers V1.02, Tab 1 RFO Instructions, 1. Submission Details d. & 3. Offer Pricing c.Offerors are welcome to provide additional documentation (such as product information, clinical data, etc.) to support their offer. Rebates/Free-of-Charge Stock, etc.; Page 31, HSQ109635These can be offered, however, Queensland Health’s preference is to receive most advantageous price for products rather than administer rebates, etc.
|
Section 2 |
Still need help? Contact Us |
---|
|
Section 3 |
Here is the detail |
---|
If there are no documents listed in this section, please refer to Section 1 Tender Overview. Documents can not be downloaded once Tender has closed. |